Literature DB >> 17322544

Urine nicotine metabolites and smoking behavior in a multiracial/multiethnic national sample of young adults.

Denise B Kandel1, Mei-Chen Hu, Christine Schaffran, J Richard Udry, Neal L Benowitz.   

Abstract

Nicotine metabolism has been hypothesized to affect patterns of smoking. The recent development of a noninvasive measure of nicotine metabolism, the nicotine metabolite ratio (trans-3'-hydroxycotinine/cotinine), makes it possible to examine the association between rate of nicotine metabolism and smoking behavior in the general population. This US study examined group differences in the ratio measured in urine and the association between the ratio and multiple measures of smoking behavior and nicotine dependence in a large, national representative sample of young adults. The sample included 900 daily smokers aged 18-26 years from wave III (2001-2002) of the National Longitudinal Survey of Adolescent Health. Nicotine dependence was measured by using the Fagerström Test for Nicotine Dependence. Females had higher nicotine metabolite ratios than males; Whites and Hispanics had higher nicotine metabolite ratios than African Americans or Asians. This finding is consistent with those from laboratory studies of older smokers based on intravenous infusion of nicotine. No significant association was found between the nicotine metabolite ratio and number of cigarettes smoked per day or nicotine dependence. The availability of a noninvasive measure makes possible systematic testing of causal hypotheses generated by laboratory studies in the general population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17322544     DOI: 10.1093/aje/kwm010

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  49 in total

Review 1.  Precision Medicine for Tobacco Dependence: Development and Validation of the Nicotine Metabolite Ratio.

Authors:  Cheyenne E Allenby; Kelly A Boylan; Caryn Lerman; Mary Falcone
Journal:  J Neuroimmune Pharmacol       Date:  2016-02-12       Impact factor: 4.147

2.  Differential success rates in racial groups: results of a clinical trial of smoking cessation among female prisoners.

Authors:  Karen L Cropsey; Michael F Weaver; Gloria D Eldridge; Gabriela C Villalobos; Al M Best; Maxine L Stitzer
Journal:  Nicotine Tob Res       Date:  2009-04-22       Impact factor: 4.244

3.  Tobacco smoke exposure and sleep: estimating the association of urinary cotinine with sleep quality.

Authors:  Moe Zandy; Vicky Chang; Deepa P Rao; Minh T Do
Journal:  Health Promot Chronic Dis Prev Can       Date:  2020-03       Impact factor: 3.240

4.  The relationship between the nicotine metabolite ratio and three self-report measures of nicotine dependence across sex and race.

Authors:  Robert A Schnoll; Tony P George; Larry Hawk; Paul Cinciripini; Paul Wileyto; Rachel F Tyndale
Journal:  Psychopharmacology (Berl)       Date:  2014-01-09       Impact factor: 4.530

5.  Race, gender, and nicotine metabolism in adolescent smokers.

Authors:  Mark L Rubinstein; Saul Shiffman; Michelle A Rait; Neal L Benowitz
Journal:  Nicotine Tob Res       Date:  2012-12-13       Impact factor: 4.244

6.  Novel Association of Genetic Markers Affecting CYP2A6 Activity and Lung Cancer Risk.

Authors:  Yesha M Patel; Sunghim L Park; Younghun Han; Lynne R Wilkens; Heike Bickeböller; Albert Rosenberger; Neil Caporaso; Maria Teresa Landi; Irene Brüske; Angela Risch; Yongyue Wei; David C Christiani; Paul Brennan; Richard Houlston; James McKay; John McLaughlin; Rayjean Hung; Sharon Murphy; Daniel O Stram; Christopher Amos; Loïc Le Marchand
Journal:  Cancer Res       Date:  2016-08-03       Impact factor: 12.701

Review 7.  Educational attainment and smoking among women: risk factors and consequences for offspring.

Authors:  Denise B Kandel; Pamela C Griesler; Christine Schaffran
Journal:  Drug Alcohol Depend       Date:  2009-01-28       Impact factor: 4.492

8.  Nicotine metabolism in African Americans and European Americans: variation in glucuronidation by ethnicity and UGT2B10 haplotype.

Authors:  Jeannette Zinggeler Berg; Jesse Mason; Angela J Boettcher; Dorothy K Hatsukami; Sharon E Murphy
Journal:  J Pharmacol Exp Ther       Date:  2009-09-28       Impact factor: 4.030

Review 9.  Nicotine chemistry, metabolism, kinetics and biomarkers.

Authors:  Neal L Benowitz; Janne Hukkanen; Peyton Jacob
Journal:  Handb Exp Pharmacol       Date:  2009

10.  The contribution of common UGT2B10 and CYP2A6 alleles to variation in nicotine glucuronidation among European Americans.

Authors:  A Joseph Bloom; Linda B von Weymarn; Maribel Martinez; Laura J Bierut; Alison Goate; Sharon E Murphy
Journal:  Pharmacogenet Genomics       Date:  2013-12       Impact factor: 2.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.